Accessibility Menu
 

Harvard Apparatus Regenerative Technology

(OTC) HRGN

Current Price$1.68
Market Cap$29.49M
Since IPO (2013)-99%
5 Year+25%
1 Year-13%
1 Month-5%

Harvard Apparatus Regenerative Technology Financials at a Glance

Market Cap

$29.49M

Revenue (TTM)

$0.00

Net Income (TTM)

$6.87M

EPS (TTM)

$-0.42

P/E Ratio

-4.03

Dividend

$0.00

Beta (Volatility)

-0.18 (Low)

Price

$1.68

Volume

50

Open

$1.68

Previous Close

$1.68

Daily Range

$1.68 - $1.68

52-Week Range

$0.94 - $2.22

HRGN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Harvard Apparatus Regenerative Technology

Industry

Biotechnology

Employees

8

CEO

Jun Li He, CFA, MBA

Headquarters

Holliston, MA 01746, US

HRGN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-321%

Return on Capital

-7%

Return on Assets

-3%

Earnings Yield

-24.81%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$29.49M

Shares Outstanding

17.58M

Volume

50

Short Interest

0.00%

Avg. Volume

2.38K

Financials (TTM)

Gross Profit

$646.00K

Operating Income

$7.62M

EBITDA

$7.62M

Operating Cash Flow

$3.83M

Capital Expenditure

$0.00

Free Cash Flow

$3.83M

Cash & ST Invst.

$1.35M

Total Debt

$199.00K

Harvard Apparatus Regenerative Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$199.00K

-339.8%

Gross Margin

0.00%

N/A

Market Cap

$29.49M

N/A

Market Cap/Employee

$3.69M

N/A

Employees

8

N/A

Net Income

$1.69M

-25.5%

EBITDA

$1.92M

-46.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.15M

-47.4%

Accounts Receivable

$16.00K

-93.1%

Inventory

$16.00K

-80.0%

Long Term Debt

$86.00K

-56.8%

Short Term Debt

$113.00K

+18.9%

Return on Assets

-2.57%

N/A

Return on Invested Capital

-6.67%

N/A

Free Cash Flow

$664.00K

-119.3%

Operating Cash Flow

$664.00K

-119.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RLFTDRelief Therapeutics Holding AG
$4.08+0.00%
NEVPFAbliva AB (publ)
$0.03+0.00%
MVRBFMedivir AB (publ)
$0.82+0.00%
MCIOFMCI Onehealth Technologies Inc.
$0.55-1.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
NVDANvidia
$177.39+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About HRGN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.